Ammar Adnan1, Mohd. Roslan Sulaiman1, Ahmad Akira1*
1. Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.
*Corresponding author: Ahmad Akira.
ABSTRACT
INTRODUCTION: The treatment of chronic pruritus that occurs with dry skin continues to be difficult to manage. Current treatments do not provide sufficient relief and may lead to unwanted side effects. Zerumbone, a sesquiterpene compound extracted from Zingiber zerumbet, shows both anti-inflammatory and antinociceptive effects, which make it a potential antipruritic drug since pruriception and nociception are thought to be mediated by similar mechanisms.
OBJECTIVE(S): The main goal of this research was to evaluate the impact of topically applied zerumbone on scratching responses in mice with dry skin.
MATERIALS & METHODS: Male ICR mice (20–30 g) were divided into six groups (n=8): naïve control, negative control (aqueous cream), positive control (1% hydrocortisone cream), and zerumbone-treated groups at concentrations of 1%, 3%, and 5%. Dry skin was induced using acetone-diethyl ether-water (AEW) treatment. Topical treatments were applied to the affected skin, and scratching behaviour was recorded for 30 minutes. A skin hydration analyser was used to assess skin moisture, oiliness, and roughness. Data were analysed using one-way ANOVA with Dunnett’s post hoc test.
RESULTS: Topical zerumbone significantly reduced scratching behaviour compared with the negative control, with the 5% formulation achieving a 60.6% inhibition rate, although it was less effective than hydrocortisone (71.9%). Zerumbone also improved skin moisture and reduced skin roughness.
CONCLUSION: Topical zerumbone demonstrates significant antipruritic activity in a murine dry skin model, supporting its potential as a therapeutic option for chronic pruritus. Further studies are warranted to elucidate its mechanisms of action and to assess long-term efficacy.
KEYWORDS: Pruritus, Zerumbone, Dry Skin, AEW Model, Itch


